Table 1. Clinical characteristic of study participants.
HIV (n = 14)AHI 4G stage 1
(n = 22)
AHI 4G stage 2
(n = 37)
AHI 4G stage 3
(n = 47)
AHI 4G stagingNAT+
4G/3G
NAT+
4G+/3G
NAT+
4G+/3G+
WB or IND
Days since HIV exposure, median [interquartile range (IQR)]NA14 (9–19)16 (13–20)19 (13–23)
Age (years), mean (SD)32.7 (6.9)28.8 (8.3)28.4 (7.3)27.8 (6.7)
Male/female ratio8/620/236/145/2
CD4 count cells/μl in plasma, median (IQR)NA526.5 (334.3–575.5)304 (237.5–457)386 (295–506)
CD8 count cells/μl in plasma, median (IQR)NA399.5 (262–482.3)240 (196–391)638 (425–1058)